Current Awards
U54 (MPI) Center for Identification and Study of Individuals with Atypical Diabetes Mellitus
Total Funding: $13,150,938
Funding Dates: July 1, 2018 – June 30, 2023
ADA A Microrna Rheostat Regulates Fuel Utilization
Total Funding: $344,679
Funding Dates: Jan. 1, 2018 – Dec. 31, 2020
NIH R01 An Anti-diabetic Microrna That Promotes Metabolically Healthy Obesity
Total Funding: $1,981,250
Funding Dates: June 1, 2017 – May 31, 2022
NIH R01 Age-related Mild Cognitive Impairment and the Protective Role of Glutathione: Implications for Alzheimer's Disease
Total Funding: $2,465,037
Funding Dates: July 1, 2017 – June 30, 2022
NIH R01 Trial of Glynac in Older Adults With Covid-19: Glutathione, Inflammation And Recovery
Total Funding: $520,809
Funding Dates: June 1, 2020 – May 31, 2021
NIH R01 (MPI) Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease
Total Funding: $4,008,075
Funding Dates: July 1, 2020 – June 30, 2025
NIH R01 Epigenomic Remodeling Of Metabolism by Exercise Through Ap-1
Total Funding: $400,000
Funding Dates: Sept. 1, 2020 – Aug. 31, 2021
NIH R01 Gender-specific Effects of Arsenic in Diabetes
Total Funding: $2,208,375
Funding Dates: Jan. 1, 2017 – Dec. 31, 2021
NIH R01 Cardiac Circadian Clock and Dilated Cardiomyopathy
Total Funding: $1,920,000
Funding Dates: July 1, 2020 – June 30, 2024
NIH R01 Does Lifestyle Intervention in Obese Older Adults Improve Bone Quality?
Total Funding: $3,830,826
Funding Dates: April 1, 2017 – March 31, 2022
NIH R01 Aromatase Inhibitors and Weight Loss in Severely Obese Men with Hypogonadism
Total Funding: $2,793,112
Funding Dates: July 1, 2017 – June 30, 2022
NIH R03 Using Insulin Pathogenic Register Specific Chimeric Antigen Receptor Redirected Regulatory T Cells to Modulate Type 1 Diabetes
Total Funding: $158,500
Funding Dates: July 1, 2019 – June 30, 2021
ADA Regulation of Hepatic Insulin Sensitivity by Hypothalamic Circadian Clock
Total Funding: $196,743
Funding Dates: Jan. 1, 2019 – Dec. 31, 2021
